COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02278510
Recruitment Status : Completed
First Posted : October 30, 2014
Last Update Posted : March 31, 2017
Infuseon Therapeutics, Inc.
Information provided by (Responsible Party):
Michael Vogelbaum, MD, PhD, Case Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 10, 2015
Actual Study Completion Date : November 10, 2015